Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-13-008393)

Filing Details

Accession Number:: 0001144204-13-008393
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-02-13 19:08:54
Reporting Period:: 2013-02-02

Filing Date:: 2013-02-13
Accepted Time:: 2013-02-13 19:08:54
Original Submission Date:: 2013-02-05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1411879	Innovus Pharmaceuticals Inc.	INNV	Blank Checks (6770)	870324697

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1478733	Bassam Damaj	4275 Executive Square, Suite 200 La Jolla CA 92037	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-02-02	250,406	$0.48	3,459,877	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,108	Indirect	Held in IRA account
Common Stock	1,297,836	Indirect	Held in name of spouse

Footnotes

On February 5, 2013, the Reporting Person filed a Form 4 reporting an incorrect amount of securities beneficially owned following the reported transaction.